Explore our vetted, EU-compliant private label product architectures. Each formula is batch-tested for trans-epidermal permeation, organoleptic stability, and clean-label international compliance.
Engineered with micronized 24k colloidal gold suspension, tri-molecular hydrolyzed marine collagen, and low-molecular hyaluronic acid to optimize extracellular matrix cellular cohesion.
Industrial-grade vacuum emulsifying homogenizer designed for viscous emulsions, micro-encapsulated dermo-cosmetic suspensions, and sanitary multi-shear oral care formulations.
Stabilized 5% nicotinamide combined with biomimetic lipid complexes and botanical tyrosinase inhibitors, targeted to mitigate photoaging, uneven hyperpigmentation, and fine lines.
Clean-chemistry hair cortex reconstruction matrix enriched with botanical coconut lipid fractions and formaldehyde-free crosslinking amino acids for structural cuticle realigning.
Triple-action cellular defense complex leveraging reduced L-glutathione, buffered niacinamide, and oligo-hyaluronic acid to scavenge free radicals and curb melanin aggregation.
Phospholipid nano-encapsulated nicotinamide adenine dinucleotide (NAD+) paired with trans-resveratrol and quercetin sirtuin stimulators for systemic mitochondrial rejuvenation.
Steam-distilled magnolia flower essential terpene fraction rich in magnolol and honokiol; clinical natural anti-inflammatories that down-regulate NF-kB-mediated chronic dermal aging.
Targeted microcirculation matrix integrating d-alpha tocopherol, micro-encapsulated caffeine, and biomimetic squalane to reduce vascular congestion and periorbital fine lines.
Units daily output capacity under automated cleanroom filling lines.
Monthly scalable throughput spanning dermo-cosmetic skin and body care.
Raw materials sourced from verified Western European chemical houses.
Proprietary clinical base formulations tested for immediate OEM deployment.
A comparative engineering assessment of leading international OEM/ODM hubs, assessing formulation capability, lead times, regulatory dossiers, and economic thresholds.
| Manufacturer / Sourcing Model | Primary Geographic Hub | Core Scientific Focus | Regulatory Alignment | Typical Lead Time | R&D Agility & Barrier |
|---|---|---|---|---|---|
| Rowe Cosmetics (Rowe Kozmetik) | Istanbul, Türkiye (Transcontinental) | Cellular longevity, liposomal serums, dermo-creams, free R&D | ISO 22716, ISO 9001, Vegan, Halal, EU (EC) 1223/2009 | 3–5 Weeks (Export Ready) | High: Free in-house pilot batches, low MOQ barrier |
| Fareva Group | France / Western Europe | Aerosol luxury skin care, large-volume dermo-cosmetics | EU / FDA / ANSM Certified | 12–16 Weeks | Low: High MOQ thresholds (>25,000 units/SKU) |
| Intercos Group | Milan, Italy | Color-infused anti-aging, luxury emulsion textures | Global GMP, ISO 22716 | 14–18 Weeks | Moderate: Heavy focus on runway seasonal launches |
| Cosmax Inc. | South Korea (APAC Hub) | K-Beauty fermented botanical extracts, fast-cycle skin barrier lotions | MFDS, ISO 22716, FDA | 8–12 Weeks | Moderate: Complex maritime transshipment into Europe |
| Kolmar Korea | Seoul, South Korea | Sunscreen filters combined with cellular UV photo-aging repair | ISO 22716, FDA OTC Registered | 10–14 Weeks | High formulation base, rigorous formula locking |
| MANA Products | New York, USA | Prestige clinical retinoids, vitamin C anhydrous suspensions | US MoCRA, cGMP, OTC | 12–16 Weeks | High domestic costs, freight tariff exposure to EMEA |
| HSA Cosmetics | Varese, Italy | High-performance trichological anti-aging hair & scalp treatments | ISO 22716, ISO 9001 | 6–10 Weeks | Specialized in hair and clinical trichology vectors |
| Bio-FD&C | South Korea | Recombinant human growth factors, synthetic biomimetic peptides | ISO 9001, Biotech Cleanroom | 8–12 Weeks | Component supplier; requires secondary filling plant |
| Mibelle Biochemistry (OEM Division) | Buchs, Switzerland | Plant stem cell culture, epigenetic actives, senolytic complexes | Swissmedic, ISO 22716 | 12–20 Weeks | Ultra-premium pricing tier, enterprise-only contracts |
| Dohmen Group / Chemovator | Germany | Clean-label minimalist dermo-cosmetic micro-emulsions | EU GMP, Dermatest Clinical | 8–12 Weeks | Rigid batch schedules, limited custom packaging runs |
Operating from Esenyurt, Istanbul, Rowe Cosmetics eliminates the traditional friction points of private labeling by consolidating laboratory formulation, regulatory safety dossiers, and automated high-shear filling under one certified roof.
Full manufacturing under strictly audited ISO 22716 GMP and ISO 9001 quality management regimes. From microbiological water deionization to inert vacuum homogenization, every batch follows pharmaceutical-level clean-in-place (CIP) protocols.
Unlike legacy contract labs that charge thousands for preliminary chemistry reviews, our internal cosmetic chemists provide formulation customization free of charge for approved customer projects.
Positioned geographically in Istanbul, Turkey, Rowe Cosmetics forms the optimal logistics bridge between Western raw chemical purity and duty-optimized global freight dispatch.
The anti-aging consumer has migrated past superficial visual moisturizing. Modern product development demands biological substantiation centered on senolytics, mitochondrial optimization, and multi-omics barrier protection.
Formulators are shifting focus toward clearing "zombie" (senescent) cells that secrete pro-inflammatory cytokines (SASP). Incorporating trans-resveratrol, quercetin, and fisetin alongside NAD+ precursors allows serums to support endogenous DNA repair mechanisms and stimulate Sirtuin-1 (SIRT1) enzymatic pathways.
Unprotected peptides and water-soluble antioxidants suffer rapid oxidative degradation. High-pressure micro-fluidization now wraps active molecules in biomimetic phospholipid bilayer liposomes, facilitating deep stratum corneum trans-membrane delivery without invoking dermal irritation or erythema.
High-growth beauty brands are pairing topical barrier repair with bio-available sublingual drops (such as our liposomal NAD+ and resveratrol complexes). This holistic regimen addresses systemic mitochondrial redox decline alongside external atmospheric photo-oxidative stress.
Modern cosmetic sourcing managers must balance inventory capital flexibility against stringent multinational regulatory compliance. Key industry-level shifts include:
Prolonged maritime transit times (35–50 days from East Asia) and volatile tariff schedules have prompted European and American brands to pivot toward Mediterranean and European periphery manufacturers. Sourcing from Istanbul reduces transit lead times to 3–7 business days overland to the EU, preserving working capital.
With the enactment of the US Modernization of Cosmetics Regulation Act (MoCRA) alongside EU (EC) No 1223/2009, private labelers can no longer afford informal documentation. Contract manufacturers must provide complete Product Information Files (PIF), Cosmetic Product Safety Reports (CPSR), and IFRA certs upfront.
Legacy factories requiring 50,000 units stifle high-growth digital native and clinic brands. The preferred modern standard relies on scalable filling lines—allowing pilot launch orders of flexible size, with built-in engineering scalability up to 1.2M units/month without switching manufacturing partners.
Detailed technical insights for cosmetic founders, procurement directors, and technical product managers.
ODM (Original Design Manufacturing) utilizes our pre-developed, clinically validated base formulas—customizing active titrations, fragrance, viscosity, and branding for the fastest timeline to market. OEM (Original Equipment Manufacturing) involves technology transfer where we manufacture, emulsify, and fill according to your exact proprietary INCI list and compounding protocol.
All candidate formulations undergo accelerated aging tests in thermal chambers (40°C–45°C and 75% relative humidity for 12 weeks), freeze-thaw challenge cycles (-5°C to 40°C), and centrifugation separation checks. In addition, ISO 11930 preservative efficacy testing ensures microbiological stability throughout the declared shelf life.
At Rowe Cosmetics, laboratory R&D support and initial pilot sample modifications are conducted free of charge for commercial production clients. Any specialized costs, such as patented proprietary bio-actives or custom tooling for injection-molded components, are quoted transparently before project execution.
Under EU Regulation (EC) No 1223/2009 and UK cosmetics law, the brand owner or an appointed third-party consulting entity serves as the legal Responsible Person (RP). As the manufacturer, Rowe Cosmetics provides the complete regulatory technical dossier—including raw material purity certificates, SDS, CPSR Part A documentation, and IFRA adherence certificates.
Yes. Our manufacturing infrastructure in Istanbul operates in compliance with Halal cosmetics protocols (free from porcine-derived materials and uncertified animal fats) and holds formal The Vegan Society registration capability, with botanical and biotechnology-derived raw materials prioritized across 95% of our supply chain.
For highly labile actives like ascorbic acid, reduced glutathione, or pure retinol, we strongly specify opaque dual-chamber airless pumps, airless pouch-in-bottle systems, or pharmaceutical-grade amber dropper glass. We conduct vacuum leak tests and compatibility assays to verify zero active leaching into container walls.
For turnkey private label (ODM) products using stock components, lead times typically run 3 to 5 weeks from label artwork and sample approval. Custom synthesis (OEM) requiring international active procurement or custom secondary packaging typically spans 6 to 8 weeks, with export-ready palletizing.
Yes. Because our factory is engineered with high-speed automated lines alongside agile semi-automated pilot lines, we offer flexible MOQ tiers that allow aesthetic clinics, dermatologists, and direct-to-consumer start-ups to launch without unmanageable capital tie-ups, scaling smoothly into million-unit runs.
